Menu
Recruiting NCT06541912

Comparative Evaluation of Implant Stability, Soft & Hard Tissue Healing Around UV Activated vs Conventional Implants

No phase Interventional UV Dental Implant

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: conventional implant, UV implant.
Who it may be relevant to
Registry conditions: UV Dental Implant. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
India
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Comparative Evaluation of Implant Stability, Soft and Hard Tissue Healing Around UV Activated Versus Conventional Implants - A Randomized Clinical Trial.

Overview

Research is to compare and evaluate the primary and secondary implant stability, healing of the soft tissue around UV activated implants and conventional implants.

Detailed description

Research is to compare and evaluate the primary and secondary implant stability, healing of the soft tissue around UV activated implants and conventional implants. The objectives are to access the primary and secondary implant stability using Resonance frequency analysis, marginal bone level using RVG with grid, healing of the soft tissue. The control group will be treated with conventional implant and test group will be treated with UV implants. The total number of participants are 12 and 24 sites (control - 12 sites, test - 12 sites) with 3 months follow up.

Interventions

  • Procedure conventional implant
    A full thickness mucoperiosteal flap was elevated under local anesthesia, osteotomy sites were prepared according to manufacturer's instructions and parallel pin was used to confirm position and angulation of osteotomy site. Conventional implant placement was done on one side. Resonance frequency analysis instrument was used to measure Implant Stability Quotient (ISQ) and check the primary stability of the implant. The surgical wound closure was done with mattress and single interrupted sutures
  • Procedure UV implant
    A full thickness mucoperiosteal flap was elevated under local anesthesia and osteotomy sites were prepared according to manufacturer's instructions. Parallel pin was used to confirm position and angulation of osteotomy site. UV implant was activated using UV Activator2 and placed in another site. Resonance frequency analysis instrument was used to measure Implant Stability Quotient (ISQ) and primary stability of the implant was measured. The surgical wound closure was done with mattress and sin

Primary outcome measures

  • Implant stability using Resonance Frequency Analysis [Time frame: "Immediately after Post-operative", "1 month", "3 months"]
Secondary outcome measures (2)
  • Marginal bone loss using RVG with grid [Time frame: "Immediately after Post-operative", 3 months]
  • Soft tissue healing [Time frame: 1 week, 1 month, 3 months.]

Eligibility criteria

Inclusion criteria

  • At east above 18 years of age
  • Patients who needs replacement for at least 2 missing teeth in the posterior region of mandible
  • Adequate bone volume to accommodate planned dental implants
  • Patients who will comply with oral health care instructions and necessary visits

Exclusion criteria

  • General contraindications to dental implant treatment ( uncontrolled diabetes, severe cardiovascular or infectious disease)
  • Intravenous and oral bisphosphonate therapy
  • Unwillingness to return for the follow up examinations
  • Smokers
  • Patients who are psychologically unable to participate
  • Poor oral hygiene

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Single group
Masking
Single blind
Primary purpose
Treatment

Study locations

India · 1 center
  • Dr. Prabhuji MLV — Bengaluru

Identifiers

NCT: NCT06541912 · 02_D012_00048

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗